DLC1 and adrenal cortex carcinoma: We demonstrated that the increase in DLC1 expression was related to a worse prognosis in ACC [overall survival (OS): P = 0.007, hazard ratio (HR) = 1.777, 95% CI = 1.166–2.708; disease-specific survival (DSS): P = 0.002, HR = 2.017, 95% CI = 1.306−3.115; progression-free interval (PFI): P < 0.001, HR = 2.156, 95% CI = 1.544–3.011] and LGG (OS: P < 0.001, HR = 2.431, 95% CI = 1.875–3.152; DSS: P < 0.001, HR = 2.765, 95% CI = 2.091−3.655; PFI: P < 0.001, HR = 2.178, 95% CI = 1.740−2.725).